Plain-English translation of NCT06763458 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a procedure called submaximal balloon angioplasty (a minimally invasive technique that gently widens narrowed blood vessels in the brain) to see if it can help prevent strokes from getting worse. You would receive this treatment in addition to the best available stroke medications. The trial is focused on people with minor strokes who are already on strong medications but whose symptoms are still worsening or fluctuating.
Even with the best medications available, people with narrowed blood vessels in the brain (a condition called intracranial atherosclerotic stenosis) have a high risk of their stroke getting worse or having another stroke soon after. Doctors believe that quickly restoring blood flow through the narrowed vessel might prevent this deterioration, and this trial will test whether the balloon procedure is a safe and effective way to do that.
You likely qualify if…
You likely don't qualify if…
If you qualify, you will be randomly assigned to either receive the balloon procedure plus standard medications, or to continue with standard medications alone. The procedure itself is minimally invasive—a thin catheter is guided to the narrowed vessel in your brain and a small balloon gently widens it. You will be closely monitored during and after the procedure, and the research team will track your recovery and symptoms over time to see if the procedure helps prevent your stroke from worsening.
AI-generated summary from trial data · Jul 16, 2026 · Not medical advice
China